In COVID -00, respiratory system findings were seen in different clinical severity.
Of note, it is also remarkable that the severity of the pneumonia (as measured by CURB-00 score) was identified to be effective on the development of NOAF. Furthermore, the presence of diffuse lung infiltration on thorax CT was determined as an independent predictor for the development of NOAF in patients with COVID-00. It is accepted that the disease enters the cell through angiotensin converting enzyme (ACE-0) receptors in the lower respiratory tract, and replication continues. Thus, pneumonia findings became prominent and determinant in the clinical course of the disease